Inspiration Biopharmaceuticals, Inc., a biopharmaceutical company focused exclusively on the development and commercialization of new treatment options for people with hemophilia, has announced the appointment of John P. Butler as Chief Executive Officer.
Being wise with your money is back in style. The recession with its attendant job losses, cut...
Roche has been named Supersector Leader in Healthcare in the Dow Jones Sustainability Indexes (...
The federal government advises throwing most unused or expired medications into the trash instead...
Time for a Change in Pharmaceutical Process Cooling?New Technology Can Greatly Reduce Water, Energy UseNovember 10, 2009 5:51 am | Articles | Comments
Recent regulatory rumblings suggest it may be time for pharmaceutical processors to take a closer look at their use of water resources. Two federal studies released in 2009 reflect increasing scrutiny of the impact manufacturers including drug companies have on the water supply.
ISPE, a global not-for-profit association of 24,000 technical professionals working in the
Genzyme Corporation announced today that it was included on both the 2009 Dow Jones Sustainability World Index and North American Index.
According to the U.S. Department of Energy, the industrial sector has long been the country's largest energy user, currently representing more than one-third of the country's total energy consumption. With this in mind, manufacturers across the United States must identify sustainable energy solutions that will drive efficiencies
Quality by Analysis (QBA) has been the MANTRA for manufacturing pharmaceuticals. This is due to the fact that, as we know, pharmaceuticals are manufactured using batch processes. Regulatory agencies would like the industry to move from QBA to QBD. QBD can result in a better batch process or a continuous process. Either of these process methodologies require a complete understanding of component chemistry and their mutual interaction.
Genzyme Corp. recently announced that revenue increased 17 percent in the fourth quarter of 2006 to $852 million, up from $729 million in the fourth quarter a year earlier. For the year, revenue grew 16 percent to $3.2 billion from $2.7 billion in the previous year.
WILMINGTON, DE (November 2, 2004) – DuPont this week announced the addition of Dr. Marcelo Carvalho de Andrade to its external Biotechnology Advisory Panel. Dr.
Herkt brings extensive industry experience and strong leadership qualities to new corporate position Emerson Process Management, an Emerson business, has announced the appointment of Melissa B. Herkt as president of Process Systems and Solutions - Americas.